AstraZeneca signs first COVID-19 vaccine supply deal with Chinese company
Shenzhen Kangtai Biological Products will produce AstraZeneca Plc's potential COVID19 vaccine in mainland China, the British drugmaker said on Thursday, its first deal to supply one of the world's most populous countries.